tirzepatide super obesity bmi 60 and health‐related quality of life in adults with or overweight: Results from the SURMOUNT‐3 phase 3 randomized trial - Gibble - 2025 - Diabetes, Obesity and Metabolism Abstract 4343077: Combination of Prolonged

Final concentration: 15 mg 1.5 mL = 10 mg/mL Practical conversion: 0.1 mL = 1 mg 0.25 mL = 2.5 mg 0.5 mL = 5 mg 0.75 mL = 7.5 mg 1.0 mL = 10 mg This dilution makes weekly titration easier

The same dual action GLP-1 and GIP mechanism behind injectable tirzepatide, delivered as a daily oral tablet

Step 5 Keeping the needle in the vial, turn the vial upside down

This dual mechanism distinguishes it from semaglutide with B12 , which targets only GLP-1 receptors

The Ozempic baby phenomenon As ovulation returns and cycles become more regular, some women on GLP-1 medications have experienced unexpected pregnancies sometimes called Ozempic babies. This can happen because weight loss and improved insulin sensitivity may restore ovulation in previously anovulatory patients, especially those with PMOS (formerly PCOS)

Maintaining weight loss after tirzepatide requires deliberate strategy: high protein intake, consistent resistance training, regular physical activity, and ongoing monitoring of weight and body composition